Pharvaris Q4 EPS $(0.80) Misses $(0.58) Estimate
Portfolio Pulse from Benzinga Newsdesk
Pharvaris reported a Q4 EPS loss of $(0.80), missing the consensus estimate of $(0.58) by 37.93%. However, this represents a 32.2% improvement over the $(1.18) loss per share from the same period last year.
April 10, 2024 | 9:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pharvaris reported a larger than expected Q4 EPS loss, missing estimates but showing year-over-year improvement.
The miss on the EPS estimate is likely to negatively impact investor sentiment in the short term, despite the year-over-year improvement. Typically, earnings misses can lead to short-term declines in stock price as they may cause investors to adjust their expectations for the company's financial health.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100